Choosing between a NOAC or a vitamin K antagonist: an approach based on risk stratification
- PMID: 28375428
- DOI: 10.1093/eurheartj/ehw644
Choosing between a NOAC or a vitamin K antagonist: an approach based on risk stratification
Comment on
-
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.Eur Heart J. 2017 Mar 21;38(12):888-896. doi: 10.1093/eurheartj/ehw565. Eur Heart J. 2017. PMID: 28064150 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
